IL10 and colitis: After six weeks, mice that had received either WT or IL-10 KO Treg-of-B cells exhibited less weight loss (Fig. 5A), milder histopathology (Fig. 5B,C), and milder colitis features (Fig. 5D) compared with mice that only received colitogenic T cells.